Shares of Roche Holding Ltd. (NASDAQ:RHHBY) have received an average recommendation of “Hold” from the twelve research firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $38.00.
A number of equities analysts have recently weighed in on the company. UBS AG downgraded Roche Holding from a “buy” rating to a “neutral” rating in a research note on Thursday, July 6th. Cowen and Company set a $38.00 price target on shares of Roche Holding and gave the stock a “buy” rating in a report on Monday, July 10th. Societe Generale cut shares of Roche Holding from a “buy” rating to a “hold” rating in a report on Friday, June 30th. Morgan Stanley reaffirmed an “equal weight” rating on shares of Roche Holding in a report on Wednesday, July 26th. Finally, BNP Paribas reaffirmed a “neutral” rating on shares of Roche Holding in a report on Tuesday, June 20th.
Several large investors have recently bought and sold shares of RHHBY. Edmp Inc. acquired a new stake in shares of Roche Holding during the second quarter worth about $207,000. Mechanics Bank Trust Department acquired a new stake in shares of Roche Holding during the first quarter worth about $217,000. Delaney Dennis R boosted its stake in shares of Roche Holding by 1.8% in the first quarter. Delaney Dennis R now owns 7,625 shares of the company’s stock worth $244,000 after buying an additional 135 shares during the last quarter. Moloney Securities Asset Management LLC boosted its stake in shares of Roche Holding by 5.9% in the first quarter. Moloney Securities Asset Management LLC now owns 9,560 shares of the company’s stock worth $305,000 after buying an additional 534 shares during the last quarter. Finally, Elefante Mark B boosted its stake in shares of Roche Holding by 9.9% in the second quarter. Elefante Mark B now owns 11,135 shares of the company’s stock worth $355,000 after buying an additional 1,000 shares during the last quarter.
Shares of Roche Holding (NASDAQ RHHBY) traded up 0.22% during trading on Tuesday, hitting $31.92. The stock had a trading volume of 410,434 shares. The company’s 50 day moving average price is $32.00 and its 200 day moving average price is $31.87. The company has a market capitalization of $217.89 billion and a price-to-earnings ratio of 21.57. Roche Holding has a 52 week low of $25.25 and a 52 week high of $36.82.
ILLEGAL ACTIVITY WARNING: This piece was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this piece on another publication, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be viewed at https://stocknewstimes.com/2017/08/05/roche-holding-ltd-nasdaqrhhby-receives-average-recommendation-of-hold-from-analysts-updated-updated.html.
Roche Holding Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
